First human tests begin for new drug KMY
Knowledge-focused
Not yet recruiting
This is the first study in people to test the safety of a new tablet called KMY. It will involve 120 healthy volunteers to see how the body handles the drug and if it causes any side effects. The study will test single doses, multiple doses, and whether food affects how the drug …
Phase: PHASE1 • Sponsor: Lei Yunshang Group • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC